BioAmber Inc. (BIOA)
-NYSE 5.84 
0.94(19.18%) Oct 1, 4:00PM EDT
| Prev Close: | 4.90 |
|---|
| Open: | 4.98 |
|---|
| Bid: | 4.75 x 5000 |
|---|
| Ask: | 6.25 x 1000 |
|---|
| 1y Target Est: | 15.00 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | 28-Oct-13 |
|---|
| Day's Range: | 4.98 - 5.95 |
|---|
| 52wk Range: | 3.96 - 10.05 |
|---|
| Volume: | 117,531 |
|---|
| Avg Vol (3m): | 29,433 |
|---|
| Market Cap: | 107.53M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- BioAmber Makes Final Yeast Milestone Payment to CargillPR Newswire(Tue, Oct 1)
- BioAmber Makes Final Yeast Milestone Payment to CargillCNW Group(Tue, Oct 1)
- BioAmber Remains A Risky Investment As It Pursues Commercializationat Seeking Alpha(Tue, Sep 17)
- Insiders Are Buying BioAmberat Seeking Alpha(Mon, Sep 16)
- BIOAMBER INC. Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Wed, Aug 28)
- BIOAMBER INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, Aug 14)
- BioAmber's CEO Discusses Q2 2013 Results - Earnings Call Transcriptat Seeking Alpha(Mon, Aug 12)
- BioAmber Inc. Earnings Call scheduled for 4:30 pm ET todayCCBN(Mon, Aug 12)
- BIOAMBER INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Mon, Aug 12)
- BioAmber Reports Second Quarter 2013 Financial ResultsCNW Group(Mon, Aug 12)
- BioAmber Reports Second Quarter 2013 Financial ResultsPR Newswire(Mon, Aug 12)
- Q2 2013 BioAmber Inc. Earnings Release - After Market CloseCCBN(Mon, Aug 12)
- BioAmber Announces Webcast of Fiscal Second Quarter 2013 Financial ResultsCNW Group(Mon, Aug 5)
- BioAmber Announces Webcast of Fiscal Second Quarter 2013 Financial ResultsPR Newswire(Mon, Aug 5)
- Bioamber: Is It Too Early To Invest In This Sustainable Company?at Seeking Alpha(Sun, Jul 21)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 33.86 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -1.85 |
|---|
| Quarterly EPS Est
(Sep-13)
: | -0.47 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
BioAmber Inc., a bio-based chemicals company, produces and sells bio-succinic acid in the United States. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into chemicals th...
View More